MedTrace Logo

Hip Denervation and Intra-articular Hydration in Damaged Hip in Axial Spondyloarthritis Patients

NCT05219084 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-05-03

No results posted yet for this study

Summary

Background: The hip joint is frequently affected in axial spondyloarthritis (SpA) of adults with destructive effects in untreated patients. About 35% of axial SpA patients had either unilateral or bilateral hip arthritis. Destruction is more common with early-onset, active disease, or enthesitis.

Objectives: The aim of this study is to evaluate the effect of hip denervation (HD) and intra-articular hydration (IAH) on pain, function score, hip mobility scores in a cohort of axial SpA patients with grade 3 and 4 hip BASRI scores.

Conditions

  • Patients With Axial SpA According to ASAS Criteria
  • Patients With Unilateral or Bilater Hip Damage According to BASRI Score
  • Age > 18

Interventions

DRUG

hip denervation

Lidocaine 2% 2ml was injected into each genicular nerve

DRUG

intra-articular hydration

10 ml; of normal; saline were injected inside the hip joint

DRUG

Combined group

hip denervation and intra-articular hydration were conducted together

DRUG

Control group

Normal; saline was injected subcutaneously

Sponsors & Collaborators

  • Suez Canal University

    collaborator OTHER

  • Sohag University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-04-15
Completion
2022-04-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05219084 on ClinicalTrials.gov